GENU-PERF: Diagnostic Value of a Biomarker of Non-surgical Knee Osteoarthritis
Study Details
Study Description
Brief Summary
Osteoarthritis is a very common pathology, especially in an aging population, and a source of disability. Based on standard radiography, the diagnosis is performed late based on the loss of the cartilage thickness. In this context, prosthetic replacement of the joint is a frequent outcome. New diagnostic biomarkers and herapeutic targets are therefore logically research priorities identified by the European League Against Rheumatisms, osteoarthritis ad hoc committee. The inflammation related to the development of this pathology is mainly studied at the cellular level and essentially in animals. Since inflammatory and vascular phenomena are closely intertwined, medical imaging of the subchondral bone vascularization appears interesting.
The dynamic contrast-enhanced T1 Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) technique allows the identification of changes in the osteoarthritic subchondral bone vascularization. In osteoarthritic animals, these changes could be identified before the cartilaginous lesions became visible, and could be correlated with the severity of osteoarthritis.
This study would be the first to correlate subchondral bone perfusion measurements (performed with the DCE sequence) of early cartilaginous lesions of the knee, identified by non-invasive MRI (T2 mapping) in humans. This examination will be performed on a 3 Tesla MRI.
If a correlation is demonstrated in the early stages of osteoarthritis in both humans and animals, then infusion of subchondral bone could become a biomarker of osteoarthritis, and serve as a follow-up evaluation of future treatments.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Osteoarthritis is a very common pathology, especially in an aging population, and a source of disability. Based on standard radiography, the diagnosis is performed late because it is based on the loss of cartilage thickness. In this context, prosthetic replacement of the joint is a frequent outcome. New diagnostic biomarkers and new therapeutic targets are therefore logically research priorities identified up today by the European League Against Rheumatisms, osteoarthritis ad hoc committee .
The strictly mechanical nature of osteoarthritis is currently being questioned. Indeed, the primitive role of inflammation in the development of this pathology is more and more discussed. This inflammation is today studied at the cellular level and essentially in animals. Since inflammatory and vascular phenomena are closely intertwined, medical imaging of the subchondral bone vascularization appears interesting.
The dynamic contrast-enhanced T1 Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) technique allows the identification of changes in the osteoarthritic subchondral bone vascularization. In osteoarthritic animals, these changes could be identified before the cartilaginous lesions became visible, and could be correlated with the severity of osteoarthritis.
In humans, a preliminary investigator study has recently shown that these changes correlate with the importance of osteoarthritic lesions in patients with advanced osteoarthritis. Up to date, no clinical study has so far been initiated to evaluate the diagnostic value of vascularization markers of subchondral bone in early knee osteoarthritis.
In this context, this prospective monocentric study aims to define the role of DCE medical imaging in the diagnosis of early (non-surgical) patella-femoral osteoarthritis.
This study would be the first to correlate subchondral bone perfusion measurements (performed with the DCE sequence) with early cartilaginous lesions, identified by non-invasive MRI (T2 mapping) in humans. This examination will be performed on a 3 Tesla MRI.
If a correlation is demonstrated in the early stages of osteoarthritis in both humans and animals, then infusion of subchondral bone could become a biomarker of osteoarthritis, and serve as a follow-up evaluation of future treatments.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| MRI of the right knee An MRI of the right knee will be done to define the role of imaging in the diagnosis of early femoro-patellar osteoarthritis. |
Diagnostic Test: MRI of the right knee
An MRI of the right knee will be done to define the role of imaging in the diagnosis of early femoro-patellar osteoarthritis.
|
Outcome Measures
Primary Outcome Measures
- Correlation between T2 cartilage value and endothelial transfer constant (Ktrans) [Thirty minutes after MRI]
T2 (transverse relaxation time) mapping can evaluate the status of the cartilage matrix and identify biochemical changes. T2 is the time constant which determines the rate at which excited protons reach equilibrium or go out of phase with each other. It is a measure of the time taken for spinning protons to lose phase coherence among the nuclei spinning perpendicular to the main field. Ktrans is a constant representing the volume transfer between blood plasma and extravascular extracellular space. its units are given in values of (1/time)
- Correlation between T2 cartilage value and reflux rate (Kep) [Thirty minutes after MRI]
The infusion pharmacokinetics parameters are as follows: Ktrans, Kep Kep represents the time constant for gadolinium reflux from the extravascular extracellular space back into the vascular system
- Correlation between T2 cartilage value and initial slope of the kinetic curve [Thirty minutes after MRI]
The infusion non-pharmacokinetics parameters are as follows: - initial slope, time at peak, area under the curve
- Correlation between T2 cartilage value and area under the kinetic curve [Thirty minutes after MRI]
The infusion non-pharmacokinetics parameters are as follows: - initial slope, time at peak, area under the curve
- Correlation between T2 cartilage value and time at peak [Thirty minutes after MRI]
The infusion non-pharmacokinetics parameters are as follows: - initial slope, time at peak, area under the curve
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients ≥ 18 years old and < 60 years old
-
Asymptomatic at the patella-femoral joint
-
Coming to perform a medical imaging examination for another indication, in the medical imaging department of the GHICL
-
Patient being informed and given free, informed and written consent to participate
-
Affiliated to the social security
Exclusion Criteria:
-
Medical history of traumatic ligamentous, meniscal or cartilaginous lesion
-
Medical history of knee surgery
-
Contraindications to MRI (pacemaker, ferromagnetic vascular clip, infusion pump, neurostimulator, cochlear implant, suspicion of metallic foreign body, claustrophobia, ...)
-
MRI with gadoteric acid injection in the 7 days preceding the MRI of the knee
-
Hypersensitivity to gadoteric acid, meglumine or any drug containing gadolinium, or any other contrast medium
-
Medical history of severe allergy, uncontrolled asthma, treatment with beta-blocker
-
Renal insufficiency: glomerular filtration less than 30 mL/min
-
Pregnant or nursing woman
-
Patient under tutorship or curatorship
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Lille Catholic Hospitals | Lomme | Nord | France | 59462 |
Sponsors and Collaborators
- Lille Catholic University
Investigators
- Principal Investigator: Jean-François BUDZIK, Pr, Lille Catholic University
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- RC-P0081